These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6972774)

  • 1. [Serum tumor markers in lung neoplasms (correlation with histological types)].
    Di Martino G; Iannucci F; Di Matteo L; Bizzarro A; Molero U; Dericoloso A
    Boll Soc Ital Biol Sper; 1981 Jan; 57(1):105-10. PubMed ID: 6972774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of GPI, AAT and CEA in primary lung neoplasms and chronic bronchopneumopathies].
    Di Martino G; di Matteo L; De Bellis G; Iannucci F; Molero U; Catena E
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):344-55. PubMed ID: 317940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of ferritin in serum of patients with lung cancer].
    Sakowicz A; Kwiek S; Wiatr E
    Pneumonol Alergol Pol; 1991; 59(9-10):38-42. PubMed ID: 1843645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins and complement components in patients with lung cancer.
    Oner F; Savaş I; Numanoğlu N
    Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood tumor markers in patients with lung cancer].
    Bianco A; Marcatili P; D'Auria D; Sorrentino P; Zofra S
    Ann Ital Med Int; 1996; 11(2):114-8. PubMed ID: 8974436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha 1-antitrypsin as a tumor marker].
    Schena M; Quadri A; Ragazzoni G; Corti P
    Quad Sclavo Diagn; 1985 Mar; 21(1):87-96. PubMed ID: 3877314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer.
    Yildirim A; Meral M; Kaynar H; Polat H; Ucar EY
    Med Sci Monit; 2007 Apr; 13(4):CR195-200. PubMed ID: 17392651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered carbohydrate content of alpha1-antitrypsin in patients with cancer.
    Rostenberg I; Guízar-Vázquez J; Peñaloza R
    J Natl Cancer Inst; 1978 Oct; 61(4):961-5. PubMed ID: 309009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
    El-Akawi ZJ; Al-Hindawi FK; Bashir NA
    Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha 1-antitrypsin content of blood serum in chronic lung diseases].
    Gud' MV
    Klin Med (Mosk); 1978 Dec; 56(12):102-5. PubMed ID: 310913
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of the determination of serum phosphohexose isomerase in malignant neoplasms].
    Bruno GF; Failla G; Foti E; Marchese V
    Minerva Med; 1978 Mar; 69(12):749-56. PubMed ID: 643216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological parameters in farmers with chronic lung disease.
    Imbriani M; Catenacci G
    Quad Sclavo Diagn; 1980 Mar; 16(1):13-8. PubMed ID: 6972544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiproteolytic activity of serum in patients with chronic pneumonia and lung cancer].
    Bugaĭ BG
    Klin Med (Mosk); 1984 Dec; 62(12):61-3. PubMed ID: 6335206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum levels of alpha 1-antitrypsin in patients with lung cancer].
    Kurgan J; Szczepański Z
    Pneumonol Pol; 1977 Aug; 45(8):549-53. PubMed ID: 302441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.